Last week the New York Times published my Letter to the Editor in response to an article about Mylan’s despicable increase of the life-saving drug Epipen, which saves people from serious allergic reactions. In “An Outcry Over the Price of Epipen,” my Letter’s focus is really on Congress and the need for them to actually do something besides talk. I note that personal drug importation, which is already happening, should not just be tolerated as a technically illegal behavior for which patients are never prosecuted but encouraged using proper guidance so that people can afford the prescriptions they need.
The other Letters provide excellent contributions to the policy debate. Caroline Poplin, who is a doctor, lawyer and healthcare analyst (wow!), criticizes drug companies for their abuse of our patent laws and federal regulations that allow them to maximize profits over patients. She believes that where the market is producing “bad results” government ought to provide remedies.
Sarah fink writes that due to the price of Epipen, her serious allergic reaction forced the plane she was on to land! Here we learn that airlines started cutting back on keeping Epipens on places due to the price. This was my favorite Letter.
Again, check it out here.Tagged with: EpiPen, letter, mylan, nytimes